Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor

690Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A conserved region in the hormone-dependent activation domain AF2 of nuclear receptors plays an important role in transcriptional activation. We have characterized a novel nuclear protein, RIP140, that specifically interacts in vitro with this domain of the estrogen receptor. This interaction was increased by estrogen, but not by anti-estrogens and the in vitro binding capacity of mutant receptors correlates with their ability to stimulate transcription. RIP140 also interacts with estrogen receptor in intact cells and modulates its transcriptional activity in the presence of estrogen, but not the anti-estrogen 4-hydroxytamoxifen. In view of its widespread expression in mammalian cells. RIP140 may interact with other members of the superfamily of nuclear receptors and thereby act as a potential co-activator of hormone-regulated gene transcription.

Cite

CITATION STYLE

APA

Cavaillès, V., Dauvois, S., L’Horset, F., Lopez, G., Hoare, S., Kushner, P. J., & Parker, M. G. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO Journal, 14(15), 3741–3751. https://doi.org/10.1002/j.1460-2075.1995.tb00044.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free